Latest News and Press Releases

CHARLOTTE, N.C., July 20, 2011 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it will release second quarter results for the period ended June 30, 2011 after...

CHARLOTTE, N.C., June 20, 2011 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced the successful completion of its dedicated QTc study of NORTHERA (droxidopa), an...

Northera Treatment Provides Durable Beneficial Effects on both Systolic Blood Pressure and the Symptoms of NOH in Patients with Multiple System Atrophy Robust Symptomatic Benefit of Northera...

Preparing to File Northera New Drug Application in Third Quarter 2011 Opening Enrollment into High Dose Arms of Phase II Trial of CH-405 for Treatment of Rheumatoid Arthritis and On Track to...

CHARLOTTE, N.C., May 9, 2011 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that an independent Data Safety Monitoring Board (DSMB) recently met to review patient...

Dr. Robert Hauser to Present Late Breaking Poster Highlighting Efficacy of Northera in Patients with Neurogenic Orthostatic Hypotension associated with Parkinson's Disease on June 8th...

CHARLOTTE, N.C., April 28, 2011 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it will release first quarter results for the period ended March 31, 2011...

CHARLOTTE, N.C., April 27, 2011 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 36th Annual Deutsche Bank Healthcare Conference at 2:50 PM ET...

FDA Informs Chelsea that Data from 306 Studies Should Not be Included as Efficacy Data in NDA FDA Confirms Reduction of Falls Endpoint in Study 306B Acceptable and Recommends Additional...

CHARLOTTE, N.C., April 5, 2011 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 10th Annual Needham Healthcare Conference at 2:00 PM ET on...